China NMPA Drug Inspection - Shanxi Wanglong Shennong Pharmaceutical Co., Ltd. - Chest-opening and Qi-regulating pills
China NMPA drug inspection for Shanxi Wanglong Shennong Pharmaceutical Co., Ltd. published January 12, 2018. Drug: Chest-opening and Qi-regulating pills. On January 11, 2018, the China Food and Drug Administration (CFDA), now known as the National Medical Products Administr
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Shanxi Wanglong Shennong Pharmaceutical Co., Ltd. published January 12, 2018. Drug: Chest-opening and Qi-regulating pills. On January 11, 2018, the China Food and Drug Administration (CFDA), now known as the National Medical Products Administr
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox